These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38347094)

  • 1. HER2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study.
    Prete AA; Angerilli V; Bergamo F; Vettore V; De Toni C; Intini R; Cerma K; Ricagno G; Cerantola R; Perissinotto E; De Rosa A; Ceccon C; Gasparello J; Denaro L; D'Amico A; Chioffi F; Carcea E; Fassan M; Lonardi S
    Br J Cancer; 2024 May; 130(8):1316-1323. PubMed ID: 38347094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study.
    Chen PC; Yeh YM; Chu CT; Su PF; Chiu PH; Lin BW; Chen SH; Lin PC; Lee CT; Chen HHW; Chen CC
    Eur J Cancer; 2023 Mar; 181():62-69. PubMed ID: 36640475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.
    Darlix A; Griguolo G; Thezenas S; Kantelhardt E; Thomssen C; Dieci MV; Miglietta F; Conte P; Braccini AL; Ferrero JM; Bailleux C; Jacot W; Guarneri V
    J Neurooncol; 2018 Jun; 138(2):369-382. PubMed ID: 29488184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of the number and total tumor burden of secondary cerebral lesions in patients with resected brain metastases of non-small cell lung cancers.
    Sauvageot S; Mollevi C; Thomas QD; Charissoux M; Darlix A; Rigau V; Bauchet L; Quantin X; Pujol JL; Roch B; Boetto J
    J Neurosurg; 2024 Jul; 141(1):89-99. PubMed ID: 38241682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib.
    Miao E; Eichholz JE; Lebow ES; Flynn J; Zhang Z; Walch H; Hubbeling H; Beal K; Moss NS; Yu KK; Meng A; Kelly DW; Gomez DR; Li BT; Rimner A; Schultz N; Drilon A; Imber BS; Pike LRG
    Lung Cancer; 2023 Apr; 178():57-65. PubMed ID: 36780766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for brain metastases in patients with metastatic colorectal cancer.
    Christensen TD; Palshof JA; Larsen FO; Høgdall E; Poulsen TS; Pfeiffer P; Jensen BV; Yilmaz MK; Christensen IJ; Nielsen D
    Acta Oncol; 2017 May; 56(5):639-645. PubMed ID: 28447565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
    Gao ZH; Li CX; Liu M; Jiang JY
    BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and prognostic significance of HER2 status in surgically resected colorectal liver metastases.
    Han J; Wang X; Zhang C; Wu Q; Ma X; Li Y; Chen Z; Zhang R; Zhang G; Lin J; Lu L; Zhu W; Jia H; Zhang J; Fan J; Chen J
    J Surg Oncol; 2022 May; 125(6):991-1001. PubMed ID: 35150441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of human epidermal growth factor receptor 2 status and systemic therapy in breast cancer with brain metastases treated with radiotherapy.
    Tsuruoka S; Kataoka M; Uwatsu K; Makita K; Tsuruoka K; Takata N; Ishikawa H; Hamamoto Y; Mochizuki T; Kido T
    Asia Pac J Clin Oncol; 2023 Jun; 19(3):347-354. PubMed ID: 36281655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of brain metastases from breast cancer: impact of targeted therapies.
    Braccini AL; Azria D; Thezenas S; Romieu G; Ferrero JM; Jacot W
    Breast; 2013 Oct; 22(5):993-8. PubMed ID: 23831232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Battaglin F; Ou FS; Qu X; Hochster HS; Niedzwiecki D; Goldberg RM; Mayer RJ; Ashouri K; Zemla TJ; Blanke CD; Venook AP; Kabbarah O; Lenz HJ; Innocenti F
    J Clin Oncol; 2024 Jun; 42(16):1890-1902. PubMed ID: 38457761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of colorectal cancer patients with brain metastases.
    Roussille P; Auvray M; Vansteene D; Lecomte T; Rigault E; Maillet M; Locher C; Dior M; Hautefeuille V; Artru P; Mabro M; Touchefeu Y; Marthey L; Moulin V; Louafi S; Lecaille C; Chautard R; Lièvre A; Zaanan A; Bennouna J; Berger A; Emambux S; Randrian V; Tougeron D
    Radiother Oncol; 2021 May; 158():67-73. PubMed ID: 33600872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry.
    Laakmann E; Witzel I; Neunhöffer T; Park-Simon TW; Weide R; Riecke K; Polasik A; Schmidt M; Puppe J; Mundhenke C; Lübbe K; Hesse T; Thill M; Zahm DM; Denkert C; Fehm T; Nekljudova V; Rey J; Loibl S; Müller V
    ESMO Open; 2022 Jun; 7(3):100495. PubMed ID: 35653983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.
    Priedigkeit N; Hartmaier RJ; Chen Y; Vareslija D; Basudan A; Watters RJ; Thomas R; Leone JP; Lucas PC; Bhargava R; Hamilton RL; Chmielecki J; Puhalla SL; Davidson NE; Oesterreich S; Brufsky AM; Young L; Lee AV
    JAMA Oncol; 2017 May; 3(5):666-671. PubMed ID: 27926948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and prognostic factors of brain metastases from colorectal cancer: a single center experience.
    Gao Z; Jin X; Wu S
    Int J Colorectal Dis; 2023 Jul; 38(1):198. PubMed ID: 37466736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis.
    Nader-Marta G; Martins-Branco D; Agostinetto E; Bruzzone M; Ceppi M; Danielli L; Lambertini M; Kotecki N; Awada A; de Azambuja E
    ESMO Open; 2022 Jun; 7(3):100501. PubMed ID: 35653982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive profiling of the immune microenvironment of breast cancer brain metastases.
    Griguolo G; Tosi A; Dieci MV; Fineberg S; Rossi V; Ventura A; Bottosso M; Bauchet L; Miglietta F; Jacob J; Rigau V; Fassan M; Jacot W; Conte P; Rosato A; Darlix A; Guarneri V
    Neuro Oncol; 2022 Dec; 24(12):2146-2158. PubMed ID: 35609559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status.
    Arrieta O; Ramírez-Tirado LA; Caballé-Perez E; Mejia-Perez A; Zatarain-Barrón ZL; Cardona AF; Lozano-Ruíz F; Segura-González M; Cruz-Rico G; Maldonado F; Rosell R
    Thorac Cancer; 2020 Apr; 11(4):1026-1037. PubMed ID: 32072746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
    Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
    Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.